Stryker's Robotics and Global Gains Offset by Macro Concerns
SYK posted strong Q2 growth driven by Mako robotics and global demand, but inflation, FX and competitive pressures temper near-term upside.
Inside Texas Instruments' $60 billion U.S. megaproject, where Apple will make iPhone chips
Apple committed to making iPhone chips at Texas Instruments' new U.S. factories. CNBC got an exclusive first look inside TI's $60 billion megaproject.
How Orchestra BioMed Is Adapting A Big Pharma Business Model To Medtech
Traditionally, medtech companies have utilized a sales-based model, but many of them are now transitioning to recurring-revenue models like subscription-based services or device-as-a-service.
The Best High-Yield Healthcare Stock to Invest $1,000 in Right Now
If you have $1,000 and a long investment horizon, this healthcare stock with a historically high yield is starting to turn its business around.
A Rise In Surgical Robotics Could Send These 2 Healthcare Stocks Soaring
And there are other reasons to invest in these companies, too.
Why Medtronic Stock Raced Higher Today
The shares benefited from a clutch of analyst price target hikes.
Medtronic Has Potential To Pursue Further Divestitures: Analyst - Medtronic ( NYSE:MDT )
Medtronic Q2 revenue hit $8.58 billion, topping $8.38 billion estimate with 8.4% Y/Y growth. Medtronic raised its FY26 sales outlook to $35.72 billion-$35.82 billion vs. the consensus $35.32 billion. Get the exact trades and sectors to target before August's biggest earnings-driven market moves.
These Analysts Boost Their Forecasts On Medtronic After Upbeat Q1 Earnings - Medtronic ( NYSE:MDT )
Medtronic plc MDT posted better-than-expected earnings for the first quarter and announced key board appointments on Tuesday, naming John Groetelaars and Bill Jellison as independent directors, effective immediately.
DexCom Expands Access and Innovation While Balancing Headwinds
DXCM grows on type 2 access, Stelo adoption, and new sensor launches, but faces margin pressures, competition and leadership transition.
Got $1,000? 2 High-Yield Healthcare Stocks to Buy and Hold Forever
Even great businesses go through hard times, which is why you'll want to look at this medical device maker and this healthcare-focused REIT today.
Why Medtronic ( MDT ) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Company News for Aug 20, 2025
Companies in The News Are: MDT, PINC, ...
Nvidia To Rally More Than 22%? Here Are 10 Top Analyst Forecasts For Wednesday - Allstate ( NYSE:ALL ) , Custom Truck One Source ( NYSE:CTOS )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. B of A Securities raised Keysight Technologies, Inc. KEYS price target from $175 to $179.
AI in Remote Patient Monitoring ( RPM ) Market to Reach USD 8,438.5 Million by 2030 | MarketsandMarkets™
Delray Beach, FL, Aug. 20, 2025 ( GLOBE NEWSWIRE ) -- The global AI in remote patient monitoring market, valued at US$1551.8 million in 2023, stood at US$1,967.7 million in 2024 and is projected to advance at a resilient CAGR of 27.5% from 2024 to 2030, culminating in a forecasted valuation of ...
Why Medtronic Stock Dropped Today
Medtronic's Q1 wasn't horrible. It also wasn't good enough to justify the stock price.
Tech Stocks Drop, Palantir Plunges 8%: Markets Today - Palantir Technologies ( NASDAQ:PLTR )
Nasdaq 100 sinks 1.4%, its worst session in two weeks, as tech stocks lead Wall Street's pullback. Cryptos erase $110 billion; Bitcoin slides below its 50-day average, Ethereum falls 4.5%. See what Wall Street is buying with instant access to ratings on 1,000 top stocks, including Goldman Sachs, ...
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields - Medtronic ( NYSE:MDT ) , Bristol-Myers Squibb ( NYSE:BMY )
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Nasdaq Down Over 300 Points; Medtronic Posts Upbeat Earnings - Laser Photonics ( NASDAQ:LASE ) , Gaxos.AI ( NASDAQ:GXAI )
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1.5% on Tuesday. The Dow traded down 0.12% to 44,859.42 while the NASDAQ fell 1.53% to 21,298.54. The S&P 500 also fell, dropping, 0.68% to 6,405.48. Real estate shares jumped by 1.5% on Tuesday.
Medtronic Lifts Outlook as Revenue Jumps
Medtronic ( NYSE:MDT ) reported first quarter fiscal 2026 results on August 19, 2025, delivering 4.8% year-over-year organic revenue growth and adjusted earnings per share ( EPS ) of $1.26, which beat the midpoint of prior guidance by $0.03 ( adjusted ) .
MDT Stock Falls Despite Q1 Earnings & Revenue Beat, FY26 EPS View Up
Medtronic tops on Q1 earnings and revenues, raises full-year EPS outlook, but shares dip on board changes.
Medtronic ( MDT ) is a Top-Ranked Growth Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
ISRG's International Push for Ion: Strategic Bet or Overstretch?
Intuitive Surgical expands Ion into Australia and Korea after 52% procedure growth, testing Asia-Pacific adoption despite budget headwinds.
What's Going On With Medtronic Stock Tuesday? - Medtronic ( NYSE:MDT )
Q1 sales hit $8.58 billion vs. $8.38 billion expected; adjusted EPS $1.26 vs. $1.23 est. FY26 sales guidance raised to $35.72 billion-$35.82 billion vs. $35.32 billion consensus. Get the exact trades and sectors to target before August's biggest earnings-driven market moves. Details here →
Medtronic Posts 7 Percent Growth in Q1
Medtronic ( NYSE:MDT ) , a global medical technology leader specializing in cardiovascular, neuroscience, and surgical devices, reported Q1 FY2026 earnings on August 19, 2025. The most notable news from the release was a strong beat on both profits and revenue: Non-GAAP earnings per share reached ...
Medtronic ( MDT ) Q1 Earnings and Revenues Top Estimates
Medtronic (MDT) delivered earnings and revenue surprises of +2.44% and +2.50%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?
Why Is Carlsmed Stock Gaining Monday? - Carlsmed ( NASDAQ:CARL )
CMS grants NTAP reimbursement of up to $21,125 for Carlsmed's spine implants. BofA forecasts 66% revenue growth in 2025, Buy rating with $16 target. Get the exact trades and sectors to target before August's biggest earnings-driven market moves. Details here → Carlsmed Inc.
Medtronic Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Medtronic ( NYSE:MDT )
Medtronic plc MDT will release financial results for the first quarter before the opening bell on Tuesday, Aug. 19. Analysts expect the Galway, Ireland-based company to report quarterly earnings at $1.23 per share, versus $1.23 per share in the year-ago period.
Top Stocks With Earnings This Week: Baidu, XPeng And More - Palo Alto Networks ( NASDAQ:PANW )
Several large retailers are reporting before Wednesday's opening bell including Target, Lowe's and TJX Companies. Walmart is set to report before the market opens on Thursday. Get more market-moving news first with AI-powered analysis that turns noise into opportunity.
Trinity Biotech's Redesigned CGM Sensor Favored by New Clinical Data
TRIB's needle-free CGM+ sensor shows accurate 15-day results with no calibration, slashing costs and boosting access.
Invivyd, Inc. ( IVVD ) Reports Q2 Loss, Lags Revenue Estimates
Invivyd, Inc. (IVVD) delivered earnings and revenue surprises of -200.00% and -23.96%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Medtronic ( MDT ) Stock Declines While Market Improves: Some Information for Investors
In the closing of the recent trading day, Medtronic (MDT) stood at $91.98, denoting a -1% move from the preceding trading day.
Insights Into Medtronic ( MDT ) Q1: Wall Street Projections for Key Metrics
Beyond analysts' top-and-bottom-line estimates for Medtronic (MDT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended July 2025.
3 Things You Need to Know if You Buy Medtronic Today
Its stock has been languishing for a while, but management is working to get back on the growth track.
Kuros Biosciences Reports First Half of 2025 Results
Ad-hoc announcement pursuant to Article 53 of the SIX listing rules ...
MDT Stock Trades Cheaper Than Peers Ahead of Q1 Earnings: Time to Buy?
Medtronic trades at a notable discount to peers as Q1 earnings loom, but rising costs and tariffs could test its resilience.
Is Franklin U.S. Low Volatility High Dividend Index ETF ( LVHD ) a Strong ETF Right Now?
Smart Beta ETF report for ...
If You're In Your 20's, Consider Buying These 3 Healthcare Stocks
If you have decades to go before you retire, you want to make sure you own companies that know how to survive and thrive.
TriSalus Life Sciences, Inc. ( TLSI ) Reports Q2 Loss, Tops Revenue Estimates
TriSalus Life Sciences, Inc. (TLSI) delivered earnings and revenue surprises of -22.73% and +5.52%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ISRG's Post-Earnings Slide: Margin Worries Overshadow Growth Story
Intuitive Surgical's Q2 revenues and procedure gains look good, but tariffs, cost inflation, and margin pressure spur a post-earnings selloff.
J&J's MedTech Unit Sales Improve in Q2: Will the Upside Continue?
Johnson & Johnson's Q2 MedTech sales beat estimates, fueled by cardiovascular gains, surgical vision growth and new product momentum.
Orchestra BioMed Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates
NEW HOPE, Pa., Aug. 12, 2025 ( GLOBE NEWSWIRE ) -- Orchestra BioMed Holdings, Inc. ( Nasdaq: OBIO, "Orchestra BioMed" or the "Company" ) , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced financial results for the ...
The Next Generation of Dividend Kings: 3 Stocks to Watch
These top dividend stocks are steadily marching toward the throne room.
Here Are Billionaire Ken Griffin's 5 Biggest Stock Holdings
A longtime leader in financial services tops the list.
Canopy Growth Corporation ( CGC ) Reports Q1 Loss, Tops Revenue Estimates
Canopy Growth (CGC) delivered earnings and revenue surprises of +6.67% and +8.81%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Surmodics ( SRDX ) Q3 EPS Turns Positive
Surmodics ( NASDAQ:SRDX ) , a medical device technology firm known for its vascular intervention products and performance coatings, released results for Q3 FY2025 on August 8, 2025. The core news was a beat on both the top ( GAAP revenue ) and bottom ( non-GAAP EPS ) lines.
Orchestra BioMed Announces Rollout of FDA-Approved BACKBEAT Global Pivotal Study Protocol Update Significantly Expanding Patient Eligibility
NEW HOPE, Pa., Aug. 08, 2025 ( GLOBE NEWSWIRE ) -- Orchestra BioMed Holdings, Inc. ( Nasdaq: OBIO, "Orchestra BioMed" or the "Company" ) , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced the roll out of a protocol ...
Medtronic ( MDT ) Rises As Market Takes a Dip: Key Facts
Medtronic (MDT) concluded the recent trading session at $91.24, signifying a +2.1% move from its prior day's close.
Verano Holdings Corp. ( VRNOF ) Reports Q2 Loss, Lags Revenue Estimates
Verano Holdings Corp. (VRNOF) delivered earnings and revenue surprises of 0.00% and -3.98%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Aurora Cannabis Inc. ( ACB ) Reports Q1 Loss, Beats Revenue Estimates
Aurora Cannabis (ACB) delivered earnings and revenue surprises of -205.56% and +6.50%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ONWARD Medical Announces the Appointment of Lucas Buchanan to its Board of Directors
EINDHOVEN, The Netherlands, Aug. 06, 2025 ( GLOBE NEWSWIRE ) -- ONWARD Medical N.V. ( Euronext: ONWD and US OTCQX: ONWRY ) , the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury ( SCI ) and other movement ...
